As of 2024-10-15, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (153.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.70 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -2796.3%.
The range of the Relative Valuation is (149.29) - (124.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.9x - 49.7x | 40.8x |
| Forward P/E multiples | 23.1x - 26.5x | 24.8x |
| Fair Price | (149.29) - (124.08) | (153.69) |
| Upside | -2719.1% - -2276.8% | -2796.3% |
| Date | P/E |
| 2024-10-14 | -1.22 |
| 2024-10-11 | -1.23 |
| 2024-10-10 | -1.15 |
| 2024-10-09 | -1.17 |
| 2024-10-08 | -1.21 |
| 2024-10-07 | -1.14 |
| 2024-10-04 | -1.18 |
| 2024-10-03 | -1.21 |
| 2024-10-02 | -1.21 |
| 2024-10-01 | -1.20 |
| 2024-09-30 | -1.23 |
| 2024-09-27 | -1.25 |
| 2024-09-26 | -1.18 |
| 2024-09-25 | -1.18 |
| 2024-09-24 | -1.27 |
| 2024-09-23 | -1.25 |
| 2024-09-20 | -1.38 |
| 2024-09-19 | -1.43 |
| 2024-09-18 | -1.44 |
| 2024-09-17 | -1.45 |
| 2024-09-16 | -1.46 |
| 2024-09-13 | -1.45 |
| 2024-09-12 | -1.41 |
| 2024-09-11 | -1.40 |
| 2024-09-10 | -1.37 |
| 2024-09-09 | -1.37 |
| 2024-09-06 | -1.34 |
| 2024-09-05 | -1.39 |
| 2024-09-04 | -1.40 |
| 2024-09-03 | -1.37 |
| 2024-08-30 | -1.54 |
| 2024-08-29 | -1.56 |
| 2024-08-28 | -1.52 |
| 2024-08-27 | -1.59 |
| 2024-08-26 | -1.60 |
| 2024-08-23 | -1.60 |
| 2024-08-22 | -1.58 |
| 2024-08-21 | -1.63 |
| 2024-08-20 | -1.57 |
| 2024-08-19 | -1.68 |
| 2024-08-16 | -1.67 |
| 2024-08-15 | -1.66 |
| 2024-08-14 | -1.67 |
| 2024-08-13 | -1.68 |
| 2024-08-12 | -1.78 |
| 2024-08-09 | -1.80 |
| 2024-08-08 | -1.86 |
| 2024-08-07 | -1.83 |
| 2024-08-06 | -1.85 |
| 2024-08-05 | -1.91 |